InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Wargacki Stephen. Director active across 1 company, notably Aquestive Therapeutics, Inc.. In total, 6 filings have been published. History available since 9 March 2023. The latest transaction was filed on 7 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Wargacki Stephen is Chief Science Officer at Aquestive Therapeutics, Inc. (XNAS). He has 6 filings in total, all for Aquestive Therapeutics, Inc., and the sampled recent filings cover the period from 2023-03-09 to 2025-03-11. In this recent sample, the modal transaction nature is Attribution, with individual amounts of EUR 86925.24536542718, EUR 50220.99923214555 and EUR 1485.465021305676.